A detailed history of China Universal Asset Management Co., Ltd. transactions in Evolus, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 12,135 shares of EOLS stock, worth $121,350. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,135
Previous 7,355 64.99%
Holding current value
$121,350
Previous $79,000 148.1%
% of portfolio
0.02%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$10.66 - $17.48 $50,954 - $83,554
4,780 Added 64.99%
12,135 $196,000
Q2 2024

Jul 19, 2024

SELL
$10.45 - $13.76 $37,766 - $49,728
-3,614 Reduced 32.95%
7,355 $79,000
Q1 2024

Apr 29, 2024

BUY
$9.99 - $14.91 $43,506 - $64,933
4,355 Added 65.85%
10,969 $154,000
Q4 2023

May 21, 2024

SELL
$7.6 - $10.53 $33,098 - $45,858
-4,355 Reduced 39.7%
6,614 $69,000
Q4 2023

Jan 23, 2024

BUY
$7.6 - $10.53 $39,178 - $54,282
5,155 Added 353.32%
6,614 $70,000
Q3 2023

May 21, 2024

BUY
$7.15 - $10.2 $5,097 - $7,272
713 Added 95.58%
1,459 $13,000
Q3 2023

Oct 30, 2023

BUY
$7.15 - $10.2 $5,097 - $7,272
713 Added 95.58%
1,459 $13,000
Q2 2023

May 21, 2024

SELL
$7.23 - $10.52 $115 - $168
-16 Reduced 2.1%
746 $5,000
Q2 2023

Jul 27, 2023

SELL
$7.23 - $10.52 $115 - $168
-16 Reduced 2.1%
746 $5,000
Q1 2023

May 21, 2024

BUY
$7.81 - $11.05 $1,491 - $2,110
191 Added 33.45%
762 $6,000
Q1 2023

Apr 27, 2023

BUY
$7.81 - $11.05 $1,491 - $2,110
191 Added 33.45%
762 $6,000
Q4 2022

May 21, 2024

SELL
$6.52 - $8.95 $67,794 - $93,062
-10,398 Reduced 94.79%
571 $4,000
Q4 2022

Jan 31, 2023

BUY
$6.52 - $8.95 $299 - $411
46 Added 8.76%
571 $4,000
Q3 2022

Oct 21, 2022

BUY
$7.76 - $13.72 $4,074 - $7,203
525 New
525 $4,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $561M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.